Mistletoe Therapy
Mistletoe is a semi-parasitic plant that grows on various host trees.
A new observational study has found that patients with late-stage non-small cell lung cancer (NSCLC) receiving supplementary Mistletoe Treatment in addition to chemotherapy were able to survive significantly longer than patients receiving chemotherapy alone.
The 2nd most studied mode of CANCER treatment after the conventional ones with over 130 clinical trials and about 3000 published research paper to its credit.
How It Works?
- Patented Oral Formulation of Mistletoe Extracts for cancer Management has the highest concentration of lectins, viscotoxins and polysaccharides for better induction of apoptosis and better immunomodulation.
- Basic research shows that Mistletoe Extracts may stimulate the immune system to fight cancer.
- Studies in humans show that Mistletoe Treatment may improve symptoms and reduce side effects of cancer treatments.
We at Indian Institute of Integrative Oncology use the purest form of Mistletoe Extracts that is in an enteric coated tablet in the dosage: 250mg, 350mg and 500mg, which is rapidly absorbed in the intestine, ensuring better bioavailability, resulting in better induction of apoptosis (cancer cell death) and better immunomodulation (increase in the immunity).
Research on Mistletoe Therapy in Cancer:
- Basic research shows that Mistletoe extracts may stimulate the immune system to fight cancer.
- Studies in humans show that Mistletoe treatment may improve symptoms and reduce side effects of cancer treatments.
- There are sufficient evidences to prove that Mistletoe can be used as supportive therapy in cancer care.
- Researchers found that Mistletoe extracts could boost survival rates among people with cancer.
- Other studies suggest that Mistletoe may reduce tumor growth and support the immune system.